 |
|
A
unique benefit to patients at the Stehlin &
deIpolyi Oncology Clinic is their immediate and
ongoing access to the research being conducted
at the CHRISTUS Stehlin Foundation for Cancer Research,
located in its own 18,000 square foot facility
on the 12 city block campus of St. Joseph Hospital
in the heart of downtown Houston.
|
| Patients
are not charged for these studies, but have immediate
access to new treatment protocols developed as a
result of this patient-focused research and treatment. |
|
|
The CHRISTUS Stehlin Foundation for Cancer Research was established
in 1969 by surgical oncologist, Dr. John S.
Stehlin, for the express purpose of conducting
basic research that can be applied directly
to improving the treatment of the patient with
cancer.
All research is clinically oriented.
|
|
|
|
The CHRISTUS Stehlin Foundation for Cancer Research conducts basic research
that can be applied directly to improving the treatment of
patients with cancer.
|
 |
The CHRISTUS Stehlin Foundation is an international leader in the development
and clinical (human) studies of a new family of anticancer drugs,
the camptothecins, which they began investigating in 1988.The
FDA authorized clinical trials to begin in 1992. More |
|
 |
 |
|
|
During
the past 31 years, the CHRISTUS Stehlin Foundation for Cancer Research
and the Stehlin & deIpolyi Oncology Clinic have pioneered
some notable firsts which have established their reputations
internationally as premier cancer research and treatment
facilities. More |
|
A valuable
community service has been provided by the CHRISTUS Stehlin Foundation
for the past 21 years with its award-winning Educational
Scholarship Program. This program provides an opportunity
for outstanding high school and college students who want
to pursue careers in science or medicine to work in the
research laboratory, observe human surgery and make rounds
with physicians. More |
|
All
research has a direct application towards improving the
treatment of patients with cancer. From the time it was
founded in 1969, the work of the CHRISTUS Stehlin Foundation has
been unique in limiting its investigations in the research
laboratory to human cancers. More |
|
|
|
|
